Clinical Trials Logo

Clinical Trial Summary

The aim of this pilot study is to evaluate the efficacy and safety of combined and simultaneous endoscopic variceal obliteration together with balloon occluded-retrograde transvenous obliteration (B-RTO) for the treatment of high-risk gastric varices


Clinical Trial Description

Although less frequent than esophageal varices, gastric varices constitute a severe and potentially life threatening complication of portal hypertension. Various methods have been described to treat gastric varices, including endoscopic and interventional radiology techniques. Endoscopic variceal obliteration (EVO) is currently considered as standard of care for the treatment of gastric varices in most centers. However, this technique is associated with significant rebleeding rates and incomplete obliteration is observed in about 50% of patients. Alternatively, few centers also use an interventional radiology technique, called balloon-occluded retrograde transvenous obliteration (B-RTO) to treat gastric varices, which has been shown to be associated with less recurrence of gastric varices and high rates of eradication of about 90%. Both techniques have their inherent weaknesses, such as frequent incomplete eradication of varices and thromboembolic events for EVO, while data suggest that B-RTO may aggravate esophageal varices.

The aim of this pilot study is to evaluate the efficacy and safety of combined and simultaneous endoscopic variceal obliteration together with (modified) B-RTO. Stopping the outflow of gastric varices by endovascular balloon occlusion may allow better endoscopic visualization, blood stagnation and thus eradication of varices, while preventing thromboembolic events. Furthermore, during study follow-up, the eradication rates and recurrence of varices, short-term and long term complications, effects of the procedure on portal pressures/hemodynamics and liver function will be evaluated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03853720
Study type Interventional
Source Centre Hospitalier Universitaire Vaudois
Contact Alban Denys, MD
Phone 0041213149768
Email alban.denys@chuv.ch
Status Not yet recruiting
Phase N/A
Start date April 2019
Completion date April 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05515861 - Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices N/A
Completed NCT04828369 - Efficacy and Safety of EUS-Guided Therapy Versus BRTO for Gastric Varices With Shunt
Recruiting NCT05614999 - The Validation and Efficacy of Varix Trainer as a Training Device Esophagogastroduodenoscopy (a Multicenter Study) N/A
Completed NCT03155256 - Treatment of Gastric Varices Using EUS Guided Techniques N/A
Recruiting NCT03171805 - The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices N/A
Completed NCT03748563 - Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis N/A
Recruiting NCT04140578 - Antibiotic Prophylaxis in Patients Undergoing GVO Phase 4
Recruiting NCT04222127 - EUS-guided Obturation of High Risk Gastric Varices Versus Standard Endoscopic Treatment N/A
Not yet recruiting NCT05500625 - Endoscopic Ultrasound-guided Coil With Cyanoacrylate Injection Versus Balloon-Occluded Retrograde Transvenous Obliteration in Managing Patients With Gastric Varices N/A
Recruiting NCT04075760 - EUS-guided Combined Therapy Versus Beta Blocker Therapy in Primary Prophylaxis o GOV II and IGV I N/A